SUBSCRIBE
SUBSCRIBE

Parkinson’s disease

Pictured: 3D illustration of stem cells used for cell therapy
Business
Kenai Emerges from Stealth With $82M Series A, Targets Parkinson’s
Formerly known as Ryne Bio, Kenai Therapeutics emerged on Thursday with backing from several groups and has a cell therapy candidate going after Parkinson’s disease.
March 1, 2024
 · 
2 min read
 · 
Tyler Patchen
Load More
PRESS RELEASES
Press Releases
UniXell Biotechnology Secures FDA IND Clearance for UX-DA003, Achieving China-U.S. Dual Breakthrough in iPSC Parkinson’s Therapy
June 24, 2026
 · 
4 min read
Press Releases
X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson’s Disease Therapy
June 23, 2026
 · 
4 min read
Press Releases
iQure Pharma Awarded Grant from The Michael J. Fox Foundation to Advance EAAT2 Program in Parkinson’s Disease
June 19, 2026
 · 
4 min read
Press Releases
Lancet Neurology study confirms staged bilateral focused ultrasound delivers substantial, durable relief for Parkinson’s disease
June 18, 2026
 · 
5 min read
Press Releases
Neuron23 to Accelerate Expansion of NEULARK Phase 2 Trial with Support from The Michael J. Fox Foundation
June 17, 2026
 · 
6 min read
Press Releases
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics
June 17, 2026
 · 
5 min read
Press Releases
IRLAB Presents Integrated Analysis of Mesdopetam Data at International Conference - Confirms Robust Efficacy Results in the Phase II Studies
June 16, 2026
 · 
3 min read
Press Releases
AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease
June 11, 2026
 · 
5 min read
Press Releases
Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson’s Disease
June 11, 2026
 · 
5 min read
Press Releases
The Jackson Laboratory secures grant from The Michael J. Fox Foundation to advance Parkinson’s disease research through the JAX-NYSCF Collaborative
June 9, 2026
 · 
4 min read
Press Releases
Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson’s Disease Programme
June 9, 2026
 · 
3 min read
Press Releases
GEN Announces First Patient Dosed in Phase II Clinical Trial of SUL-238 in Parkinson’s Disease
June 8, 2026
 · 
3 min read
Press Releases
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson’s Disease
June 5, 2026
 · 
10 min read
Press Releases
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
June 4, 2026
 · 
8 min read
Press Releases
NeuraLight Biomarkers Reveal What Parkinson’s Gold-Standard Measurement Scale Misses in a Study Led by the Scale’s Own Developers
June 4, 2026
 · 
4 min read
Press Releases
IRLAB Participates at Aktiedagarna in Stockholm on June 9
June 3, 2026
 · 
1 min read
Press Releases
Neuropacs Announces the Publication of a New Study Comparing the First‑of‑Its‑Kind FDA De Novo–Classified Imaging Biomarker for Parkinson’s Disease with CSF Alpha‑Synuclein Seed Amplification Assay
June 2, 2026
 · 
5 min read
Press Releases
Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096
June 2, 2026
 · 
6 min read
Press Releases
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TMEM175 Agonists for Parkinson’s Disease
June 1, 2026
 · 
3 min read
Press Releases
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson’s and Rare Epilepsy AI Discovery Collaboration
May 28, 2026
 · 
5 min read
Load More